Advanced Filters
noise
Found 1,917 clinical trials
S Sebastien Couraud, Prof

Mobile Lung Cancer Screening

Lung cancer screening using low-dose CT (LDCT) has been shown to reduce mortality in high-risk populations. In 2022, the French National Cancer Institute (INCa) issued guidelines recommending screening for individuals aged 50-74 with a history of heavy smoking, including current smokers or those who quit less than 15 years ago. …

50 - 75 years of age All Phase N/A
S Soraya Fenniche, MD

Tunisian Lung Cancer Study

This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.

18 years of age All Phase N/A
R Rita Mehta, MD

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened …

18 - 80 years of age All Phase N/A
A Allison Chang, MD

LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B

This research is being done to determine if an image-based deep learning model (Sybil) can accurately predict the likelihood of future lung cancer based on chest computed tomography (CT) imaging from individuals with a family history of lung cancer.

18 years of age All Phase N/A

Lung cAncer Robotic Comparative Study

To compare outcomes of minimally invasive surgical techniques for the treatment of early-stage non-small cell lung cancer.

18 years of age All Phase N/A
J James J. Tsay, MD, MSc

Lung Cancer Biomarkers and Screening

RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.

50 years of age All Phase N/A
Y Yongchang Zhang, MD

Survival Outcomes of Lung Cancer

This is a prospective study to analyze the survival outcomes of different groups about lung cancer patients.

18 years of age All Phase N/A
S Sarah Neufeld

Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer

Determine whether CT-based multiparametric analytical models may improve prediction of biopsy and treatment outcome in patients undergoing screening CT scan and/or treatment for early stage lung cancer

18 - 99 years of age All Phase N/A

Rural Illinois Lung Cancer Screening Initiative

The role of this observational study is to access the feasibility of providing lung cancer screening using a designated nurse navigator through lung cancer screening clinic. Eligible participants will be identified using medical records, eligibility will be confirmed through phone call, screening visits will be scheduled as in-person visit or …

50 - 80 years of age All Phase N/A
O Oscar Arrieta, MD MSc

Lung Cancer Screening Program in Mexico

This prospective study aims to detect early-stage lung cancer using low-dose computed tomography (LDCT) in Mexicans aged 50 or older who are current or former heavy smokers, non-smokers exposed to significant wood smoke, or diagnosed with COPD. Annual LDCT, spirometry, and serum biomarker tests will be conducted over 3 years, …

50 years of age All Phase N/A

Simplify language using AI